Illumina Settles Allegations of Cyber Vulnerabilities in Genomic Sequencing for $9.8M - Claims Journal
Illumina Inc. has agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act after the company sold genomic sequencing systems with cybersecurity vulnerabilities to fed...